SM
NXTM

Sabby Management’s NxStage Medical Inc. NXTM Stock Holding History

Sabby Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50,542
Closed -$722K – 425
2015
Q2 		$722K Buy
+50,542
New +$856K 0.03% 238

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Sabby Management's NXTM Position: Q3 2015 in Review

Sabby Management sold out of NxStage Medical Inc. (NXTM) in Q3 2015, closing a stake of 50,542 shares — an estimated $722K sold.

Sabby Management first reported a position in NXTM in Q2 2015 and held it in 1 quarter. The position peaked at $722K in Q2 2015. 127 funds tracked by Wall St. Rank hold NXTM as of Q3 2015.

  • Sabby Management reported no remaining NxStage Medical Inc. position as of Q3 2015 after selling out during the quarter.
  • Sabby Management sold 50,542 NxStage Medical Inc. shares in Q3 2015, an estimated $722K.
  • Sabby Management first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 1 quarter.
  • Sabby Management's NxStage Medical Inc. position peaked at $722K in Q2 2015.
  • 127 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.